Northern Trust’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.03M Buy
362,180
+21,774
+6% +$299K ﹤0.01% 2453
2025
Q4
$4.7M Sell
340,406
-13,707
-4% -$322K ﹤0.01% 2508
2025
Q3
$8.65M Buy
354,113
+12,271
+4% +$299K ﹤0.01% 2195
2025
Q2
$7.9M Buy
341,842
+42,623
+14% +$1.12M ﹤0.01% 2205
2025
Q1
$8.08M Sell
299,219
-9,581
-3% -$361K ﹤0.01% 2167
2024
Q4
$16.5M Buy
308,800
+42,302
+16% +$2.24M ﹤0.01% 1817
2024
Q3
$12.1M Buy
266,498
+72,125
+37% +$3.14M ﹤0.01% 1958
2024
Q2
$8.14M Sell
194,373
-7,610
-4% -$357K ﹤0.01% 2106
2024
Q1
$7.6M Sell
201,983
-2,019
-1% -$44K ﹤0.01% 2220
2023
Q4
$2.19M Buy
204,002
+11,317
+6% +$97.9K ﹤0.01% 2950
2023
Q3
$1.94M Buy
192,685
+5,395
+3% +$62.2K ﹤0.01% 2960
2023
Q2
$2.22M Buy
187,290
+47,319
+34% +$632K ﹤0.01% 2952
2023
Q1
$1.69M Buy
139,971
+243
+0.2% +$4.04K ﹤0.01% 3006
2022
Q4
$1.84M Buy
139,728
+3,364
+2% +$49.2K ﹤0.01% 3047
2022
Q3
$1.85M Buy
136,364
+3,207
+2% +$42.8K ﹤0.01% 3048
2022
Q2
$1.63M Sell
133,157
-7,090
-5% -$83.9K ﹤0.01% 3168
2022
Q1
$2.01M Buy
140,247
+24,752
+21% +$405K ﹤0.01% 3103
2021
Q4
$2.28M Sell
115,495
-1,466
-1% -$30.7K ﹤0.01% 3161
2021
Q3
$2.53M Buy
+116,961
New +$3.37M ﹤0.01% 3150

Other funds holding JANX